Vol. 13, Issue 3, 2022September 30, 2022 EDT
ccby-nc-sa-4.0
Prevalence, relegation or resurruction: the future of single interfering RNA and antisense oligonucleotide APIs.
Prevalence, relegation or resurruction: the future of single interfering RNA and antisense oligonucleotide APIs.
siRNAAntisense oligonucleotideExcipientsBioactive excipientOrphan diseaseGene silencingGene knockdownRepurposed
Apte, Shireesh P. 2022. “Prevalence, Relegation or Resurruction: The Future of Single Interfering RNA and Antisense Oligonucleotide APIs.” International Journal of Pharmaceutical Excipients 13 (3).